Cologne, Germany / Walkersville, MD (USA), 12 October 2015 – Lonza has announced that it will host a free 60-minute webinar on 27 October and 28 October 2015, entitled “Enhance Your Cell Culture with RAFT™ 3D Cell Culture System.” The webinar will be of interest to all researchers performing cell culture. It will demonstrate how to use this novel 3D cell culture system to create high-density collagen scaffolds with embedded cells and improve cellular interactions to more closely resemble an in vivo environment.
To help researchers learn more about the RAFT™ 3D Cell Culture System, specialists from Lonza will be addressing the following questions and topics during the webinar:
· Why does the RAFT™ 3D System replicate in vivo conditions better than other cell culture methods?
· What are the key applications for which the RAFT™ 3D Culture System has been successfully used?
· Why is the RAFT™ 3D System the right choice for researchers?
Interested parties can register to attend the free webinar by selecting the link alongside their preferred date below:
Speaker: Andrew Winner, Scientific Support Specialist, Lonza Walkersville
Speaker: Dr. Nazim El-Andaloussi, Scientific Support Specialist, Lonza Cologne
About Lonza
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life.
Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 9,800 full-time employees worldwide. The company generated sales of about CHF 3.64 billion in 2014 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Further information can be found at www.lonza.com.
Lonza Contact Information
Lonza Cologne GmbH |
Lonza Group Ltd |
Lonza Group Ltd |
Manager Marketing Communications |
Head Corporate Communications |
Head External Communications |
Petra Haberkamm |
Dominik Werner |
Constance Ward |
Tel +49 221 991990 |
Tel +41 61 316 8798 |
Tel +41 61 316 8840 |
Fax +49 221 99199498 |
Fax +41 61 316 9540 |
Fax +41 61 316 9840 |
|
|
|